Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada for the prevention of lower respiratory tract disease (LRTD) caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback